Neurological Therapeutics
Online ISSN : 2189-7824
Print ISSN : 0916-8443
ISSN-L : 2189-7824
 
Multiple sclerosis―Treatment of complications― (from Multiple sclerosis/neuromyelitis optica clinical practice guidelines 2017)
Yuko Shimizu
Author information
JOURNAL FREE ACCESS

2021 Volume 38 Issue 4 Pages 411-414

Details
Abstract

Multiple sclerosis (MS) is a chronic inflammatory demyelinating disease of the central nervous system and combined with various clinical symptoms. The invisible/hidden symptoms of MS, that pain and numbness, fatigue, dysuria, depression, and cognitive dysfunction other than MS motor dysfunction are hard to detect and understand from the outside. Therefore, it is easy to misunderstand at family life and employment. It might be significantly hindrance the patient's quality of life (QOL). In the daily medical care of MS patients, not only the effect of suppressing relapse and/or progression by disease modifying drug, but also understanding the various those complications of the patient and taking appropriate measures will lead to the improvement of QOL by responding to the unmet medical needs of the patient. This paper outlines about the treatment of MS complications based on 「Multiple sclerosis / neuromyelitis optica clinical practice guidelines 2017」.

Content from these authors
© 2021 Japanese Society of Neurological Therapeutics
Previous article Next article
feedback
Top